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Abstract 
Adolescents and young adults (AYA) with cancer are an understudied group. Much of what is 
known about long-term outcomes after AYA cancer has been derived from cohorts of childhood 
cancer survivors, which seldom include patients at the older end of the AYA age spectrum. In 
general, AYA cancer survivors have a lower risk for premature mortality, subsequent primary 
neoplasms and chronic health conditions than childhood cancer survivors. However, AYA 
cancer survivors are vulnerable to psychosocial challenges, concerns about fertility and 
relationships, and financial toxicity.  No single model is optimal for the care of these survivors, 
but it is generally agreed that all survivors require a survivor care plan that promotes their 
adherence to evidence-based surveillance guidelines. There is a need to create survivor cohorts 
that include the full range of AYA ages and diagnoses to be able to address the many pressing 
questions that remain unanswered in this vulnerable population.   
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Introduction 
There are approximately 70,000 new cancer diagnoses in adolescents and young adults (AYA; 
aged 15-39 years[1]) in the United States each year, while globally, almost one million 20-39 
year olds are diagnosed with a new cancer annually.[2] Cancer is the leading cause of disease-
related (non-injury) death in AYA.[3,4]  Although survival rates for many AYA cancers are 
good, improvements in survival have lagged behind those observed in children and older adults. 
This has been a focus of recent research;[4-7] however, less attention has been given to 
morbidity among long-term survivors. The number of survivors and their burden on the health 
care system continues to rise, but in many jurisdictions, health care professionals,[8,9] legislators 
and other stakeholders have limited knowledge about this population’s special needs.  
Furthermore, resources to fund research, create specialized clinical programs including survivor 
programs and increase awareness are often inadequate.[10]  In this article, we focus on key 
issues relating to survivors of AYA cancers. We compare the risk of late effects of therapy 
between survivors of AYA and childhood cancer and explore three critical challenges faced by 
AYA cancer survivors: fertility and sexuality, psychosocial outcomes, and financial 
consequences. We discuss the obstacles to providing lifelong, risk-based care to AYA cancer 
survivors. Lastly, we describe ongoing research into AYA survivor outcomes, and explore the 
research gaps and opportunities that should shape the future direction of AYA survivor research.  
International cohorts available for the study of AYA cancer survivors 
There is a large number of survivorship cohorts internationally, but most were established with 
the aim of assessing late effects among childhood cancer survivors, with the upper age band of 
the cohort often extending only to survivors of adolescent cancer. We identified only two large 
AYA survivorship cohorts (from the United Kingdom and Denmark) that covered the entire age 
4 
 
range of 15-39 years. Thus, while cohorts such as the North American Childhood Cancer 
Survivor Study (CCSS) and Adult Life after Childhood Cancer in Scandinavia (ALiCCS) have 
provided a wealth of knowledge regarding late effects for younger patients, their findings are 
largely driven by the often greater risks observed among survivors diagnosed before the age of 
15 years, and not generalizable to the entire population of survivors of AYA cancer. Thus, there 
is a need to establish cohorts assessing AYA, particularly above the age of 25. We have 
highlighted some characteristics of selected survivorship cohorts in Table 1, which have 
informed our comparison of the risks of adverse outcomes in survivors of AYA and childhood 
cancers.   
 
Risks of adverse physical outcomes in survivors of AYA cancer  
AYA experience increased risks of premature mortality and morbidities compared to the general 
population. Serious late effects can occur in all organ systems depending on treatment exposures, 
and can impact mental health. Much of what is currently “known” about late effects in AYA has 
been extrapolated from childhood cancer survivors. It is important to recognize there are 
differences in risks between these two vulnerable populations. In this section we compare risks 
in survivors of childhood and AYA cancers for three of the most common late effects: late 
mortality, subsequent primary neoplasms (SPNs), and chronic health conditions.  
 
Late mortality 
Numerous investigations into mortality have been undertaken among survivors of childhood 
cancer, but little is known about the risks in AYA, with no study to date documenting the risk of 
all-cause mortality among those diagnosed between 34-39 years. Among the studies that were 
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identified, survivors of AYA cancers were generally observed to have lower risks compared to 
childhood cancer survivors. For example, in Scotland, the risk of all-cause mortality was 11.0 
times higher in childhood cancer survivors compared to the general population, whilst the 
corresponding risk in those diagnosed aged 15-24 was 4.7 times higher.[11] Similar differences 
were observed in Finland when comparing survivors of cancer diagnosed at 0-19 years with 
those diagnosed at 20-34 years.[12] The risks were more comparable between survivors of 
childhood and AYA cancers in the institution-based CCSS.[13] Neoplastic-related deaths 
(relapse, SPN) are the main cause of premature mortality in both age groups, followed by 
infection and cardiovascular diseases.[12] Cause-specific mortality risks were also attenuated for 
AYA survivors compared to survivors of childhood cancer,[12,14,15] with standardized 
mortality ratios (SMRs) decreasing from 6.8 to 1.7 for respiratory deaths[14] and from 3.4 to 1.4 
for cardiac deaths.[15,16]   
 
Subsequent primary neoplasms  
Radiotherapy, chemotherapy, and genetic predisposition have all been associated with increased 
SPN risks among cancer survivors. Compared to research in children, the vast majority of studies 
in AYA have been on specific diagnosis groups, such as testicular cancer,[17,18] breast 
cancer,[19-23] and Hodgkin lymphoma.[24-26]  Only two studies[27],[28] have addressed the 
risk of SPNs after each AYA cancer diagnosis, and only the former assessed the risks of specific 
types of SPNs after each particular AYA cancer.  
 
While the SPN standardized incidence ratios (SIRs) in children range from three- to six-fold that 
expected,[28-36] the SIRs are substantially smaller in AYA, with the Surveillance, 
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Epidemiology, and End Results (SEER) program reporting an SIR of 1.6 among 15-39 year olds 
(corresponding SIR in children in SEER=4.3).[28] Excess risks of SPNs vary substantially when 
assessed by type of SPN and by interval from diagnosis of index cancer.  For example, if we 
compare the SPN-specific risks in two United Kingdom population-based studies, the British 
Childhood Cancer Survivor Study (BCCSS) and the Teenage and Young Adult Cancer Survivor 
Study (TYACSS), we observe SIRs varying from 1.9 for genitourinary SPNs to 30.5 for bone 
SPNs in the BCCSS.[29] This is a far greater variation compared to AYA in the TYACSS where 
the SIRs varied from 1.1 for breast SPNs to 3.0 for meningiomas.[27] Similarly, if we compare 
the SIRs for breast cancer after Hodgkin lymphoma in female survivors, the estimate in the 
BCCSS was 8.9, over twice as high as the corresponding estimate in the TYACSS 
(SIR=3.2).[27,29] There are a number of factors which may be related to these differences 
including the potential for greater toxicity in tissue and organs exposed to cancer treatments 
whilst still developing and the different spectrum of malignant diseases predominating in 
childhood and AYA and the consequent different treatment exposures.  
 
Chronic health conditions 
Reports regarding chronic health conditions among AYA cancer survivors have largely focused 
on hospitalizations.[37-42] Childhood cancer survivors have been estimated to experience 
approximately twice as many hospitalizations compared to controls,[43] while the corresponding 
excess risk in AYA cancer survivors was 1.4.[39] Conditions associated with the greatest excess 
risks in AYA were hospitalizations for blood, infectious and parasitic disease, and SPNs, all of 
which were at least 50% more likely in AYA cancer survivors than comparative norms.[39] 
Greatest excess risks of hospitalizations among childhood cancer survivors were associated with 
7 
 
nervous system, blood, and endocrine diseases.[43] Again, childhood cancer survivors exhibited 
greater excess risks than AYA cancer survivors.  
 
As only one study described above assessed all types of hospitalizations,[39] the remaining body 
of literature on chronic health conditions in AYA has focused on specific types of diseases, 
mostly circulatory outcomes. In the several reports from Finland comparing survivors of cancer 
diagnosed aged 0-19 years with those diagnosed aged 20-34 years, risk of cardiovascular 
morbidity was 13.5 times and 3.6 times higher respectively than expected from sibling 
controls.[37] The likelihood of purchasing cardiovascular medicines has been shown to be 
significantly higher in survivors of childhood (hazard ratio (HR) = 19.8) than AYA cancer (HR = 
2.5).[44] These risks were more elevated than those observed in the Yorkshire Specialist 
Register of Cancer in Children and Young People (YSRCCYP) and Danish Cancer Registry, 
where AYA aged 15-39 years at diagnosis were only 1.3 times more at risk for a hospitalization 
for cardiovascular disease compared to the control group in the latter cohort.[38,42] 
Hospitalizations due to endocrine diseases have also been studied in AYA in one study from 
Denmark, where survivors had a 70% greater risk than controls of having a condition;[41] this 
was substantially lower than the corresponding 4.8 times increased risk reported by the ALiCCS 
cohort.[45]  
 
These initial reports provide important information, but the general lack of knowledge on the 
total burden of disease in AYA cancer survivors is concerning. With 99.9% of childhood cancer 
survivors experiencing a chronic health condition by age 50 years, and 96% of these survivors 
having a severe or disabling, life threatening or fatal condition by the same point,[46] it is critical 
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to understand the magnitude of morbidity in survivors of AYA cancers in order to provide 
evidence for clinical follow-up guidelines and preventative interventions.   
 
Major challenges faced by AYA cancer survivors  
AYA cancer patients face developmental challenges that are distinct from other age groups with 
cancer, and that exceed the challenges faced by other young people their age. These hardships 
arise from the fact that AYA are diagnosed with cancer during a period of development in which 
they form individual values and identity, and create strong personal relationships. Many AYA 
with cancer are still developing autonomy, and have less developed coping mechanisms and 
decision making skills which are critical when faced with a cancer diagnosis and medical 
decisions. As a result of their stage in life, AYA are likely to experience specific needs, 
particularly in relation to psychosocial problems, fertility, and financial stability.  
 
Psychosocial outcomes 
Adolescence and young adulthood are stages in life with increased vulnerability to stress. This 
vulnerability results in even greater psychosocial needs among AYA with a history of 
cancer,[47-50] with studies reporting poorer mental health,[48] health-related quality of life,[51-
53] and social functioning,[54] as well as 2.5 times more fatigue.[55] These challenges, which 
occur throughout the cancer care continuum (i.e. from diagnosis to survivorship or end of life), 
span several domains of stress and coping,[56] and are likely related to multiple factors such as 
cancer-related distress in the short- and long-terms, altered relationships, and concerns about 
body-sexual image, interrupted future plans, and forced dependence.[57,58]  
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AYA live with a heightened awareness of the uncertainties in life due to their cancer diagnoses. 
Fears of recurrence, late effects of therapy, and death are common examples of cancer-related 
distress. While the availability of data on this topic remains limited, several studies have 
suggested that AYA survivors experienced higher levels of fear of recurrence than older cancer 
survivors.[59-62]  These fears can impact mental health, self-perceptions, family concerns, and 
finances.[63,64]  AYA survivors experience more depression compared to other survivors, with 
one study finding that 16% of AYA survivors met the clinical criteria for depression.[65] 
Elevated risks for suicidal ideation,[66,67] anxiety,[68] and post-traumatic stress disorder 
(PTSD)[69-71] have  also been noted in this population. AYA survivors from a Norwegian 
cohort were 2.6 times more likely to commit suicide than their peers,[72] and separate studies 
have shown a 4-5 times higher risk of PTSD compared to siblings[73] or comparative norms.[74] 
Interventions have been developed to assist survivors with many of these psychosocial issues, 
but the inclusion of AYA in these studies remains limited, and more work is needed to design 
specific strategies for this age group.[75]  
 
Fertility and interpersonal issues 
Infertility and childbearing difficulties remain major concerns for all AYA cancer survivors who 
have not yet completed their families, regardless of their diagnosis, prognosis, or treatment.[76-
78] Although health provider awareness of treatment-related fertility damage is improving,[1] 
many AYA lack awareness of gonadotoxic treatments and their related reproductive impact.[79] 
AYA have reported limited knowledge about their reproductive health,[80-82] and fertility 
information is one of the most cited unmet needs among AYA survivors.[83-85] This is 
particularly apparent in younger patients, where the overprotectiveness of parents and discomfort 
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among clinicians[79] may hinder the patient’s ability to receive adequate information and 
support or be involved in fertility-related decisions.[86] Consequently, there have been numerous 
recommendations for increased counselling and referral of patients to reproductive specialists 
before treatment.[87-89] International guidelines for fertility in males and females have also 
advanced substantially in the past few years to support a common vision and integrated strategy 
for monitoring these patients,[90,91] though further work is necessary to provide family building 
support  given the emotional and financial burdens faced by AYA survivors.  
 
Cancer and its treatment can have a large impact on sexuality, intimacy and the formation of 
mature, committed relationships.[1] It can be difficult for the AYA cancer patient and their 
parents, partners and friends to discuss these issues. Numerous studies have highlighted the 
negative impact on interpersonal relationships of having a cancer, with it not being uncommon 
for these patients to experience isolation or changes in friendships.[1,57,92] However, one study 
did suggest that most young survivors report improved family relationships, which is a critical 
component of health and wellbeing.[1] Body image and sexuality can also be compromised 
among AYA cancer survivors.[57,92-95] For example, one study found that 52% of breast 
cancer survivors reported having a small problem in two or more areas of sexual functioning.[94] 
Whilst findings consistently show that AYA patients experience sexual problems and need 
support with sexual issues, one study found that 76% of AYA rated their relationship quality as 
high,[96] suggesting that AYA can cope with these struggles if sufficient information and 
support is provided.  
 
Financial consequences 
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Cancer can interfere with educational and occupational goals both during treatment and for years 
afterwards. Diagnosis and treatment can have substantial effects on the AYA’s ability to return 
to school or participate in the labour force.[1,97] As a result, cancer during adolescence and 
young adulthood can have a significant influence on the survivor’s career development and 
potential earnings.[98] This is exemplified by the fact that cancer survivorship is associated with 
lost productivity due to fewer hours worked and more missed work days.[98-101] For example, 
in the United States, the annual excess economic burden of cancer survivorship was $5,320 per 
AYA survivor;[98] 41.5% of this total was due to lost productivity, which was substantially 
higher than that observed in older cancer survivors.[98]  
 
Financial worries and instability may also result in AYA avoiding routine medical care. Research 
has shown that AYA cancer survivors face higher out-of-pocket expenditures than their peers 
without cancer, with significantly higher costs noted for ambulatory care and prescriptions.[98] 
Similarly, AYA survivors may avoid care because it would require missing work and lower their 
income, making it then difficult to pay household bills. Indeed, in a study of AYA cancer 
survivors receiving financial assistance grants, 92% of the financial support provided was to 
support non-medical costs, of which rent/mortgage accounted for 62%.[102] Such findings 
suggest that AYA need additional support in order to maintain an appropriate income while 
receiving recommended care, particularly in settings without universal healthcare.[98]  
 
Intervention studies aimed at prevention, earlier diagnosis or otherwise reducing the 
impact of late physical effects in AYA cancer survivors 
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We undertook a systematic review of the literature to identify interventions aimed at preventing, 
diagnosing or mitigating the impact of late effects in survivors of AYA cancer (see Appendix A 
for search strategy and study selection). We attempted to exclude studies which related 
exclusively to survivors of childhood cancer. Two previous systematic reviews of the literature 
have been completed addressing these issues.[103,104] In the first, Pugh et al identified 12 
studies, nine of which were randomised clinical trials. They report that six of the 12 changed 
health behavior (see Table 2 for details). Physical activity, smoking, alcohol and diet were 
targeted by eight, five, four and three of the studies, respectively. In the second review, Kopp et 
al identified six studies, four of which were randomised clinical trials. Physical activity was 
targeted by all studies, while one also targeted smoking and alcohol, and another also targeted 
diet. Most survivors included in the studies comprising each systematic review had experienced a 
haematological neoplasm or a brain tumour, which are relatively uncommon among AYA 
survivors. With some notable exceptions, sample sizes were generally small with the inevitable 
consequences for statistical power. The duration of follow-up of many studies was limited.  
We identified 11 primary studies, which did not appear in either systematic review, of which 
seven have been completed and four are on-going (Table 2). Nine of these targeted physical 
activity, one targeted sun protection and the remaining study targeted smoking. Again, sample 
sizes were relatively small except for two studies with at least 100 participants.[105,106] Gill et 
al concluded that a week-long outdoor adventure therapy camp increased physical activity levels 
during camp and for 3 months after camp termination. Emmons et al concluded that print and 
web format interventions yielded equivalent levels of success in smoking cessation; these were 
comparable to those found in a previous telephone-delivered intervention.   
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Given the potential role of lifestyle factors in the excess risk of strokes[40] and SPNs[27] 
reported among survivors of AYA cancer, further clarification is needed of the extent to which 
lifestyle factors are involved in the development of these outcomes and which interventions 
could  target lifestyle factors with strongest effect. 
 
Provision of care to survivors of AYA cancer 
There is no single provider type or location of “risk-based” care that is ideal for all survivors of 
AYA cancer. Similar to models of care in place for young adult survivors of childhood cancers,  
several care models have been proposed for AYA cancer survivors,[107] including dedicated 
care at a specialized survivor clinic (in a cancer center) or shared care between a survivor clinic 
and a primary care physician, such as a family doctor or general internist.[108,109] 
Unfortunately, there has been less focus on building specialized survivor clinics for AYA cancer 
survivors than there has been for childhood cancer survivors. Initiatives have been launched in 
several countries to develop systems for providing specialized care to AYA cancer survivors. 
Canteen in Australia (https://www.canteen.org.au/wp-content/uploads/2016/09/Adolescent-and-
Young-Adult-Cancer-Survivorship-Report.pdf  and the Teenage Cancer Trust 
(https://www.teenagecancertrust.org/sites/default/files/Blueprint-of-Care.pdf) in the United 
Kingdom are two examples, although neither caters to those in their late 20’s or 30’s.  In 
addition, numerous institutions around the world have developed specialized AYA survivor 
clinics. However, most survivors of AYA cancers do not have access to such specialized 
services. Some obtain their long-term follow-up in a general cancer clinic, often from the same 
oncology team that provided their initial cancer therapy. Many survivors report feeling most 
comfortable remaining with their treating oncologist given that physician’s familiarity with their 
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cancer treatment history.[110] However, these clinics often focus primarily on relapse detection 
rather than surveillance for late effects. After a certain period, survivors are frequently 
discharged back to their primary care physicians, who must then assume responsibility for long-
term follow-up. This may be problematic given the professed discomfort and limited knowledge 
of many primary care physicians surrounding evidence-based follow-up care for young cancer 
survivors.[8,9] Finally, some survivors have no regular source of follow-up care at all. Thus, for 
many survivors of AYA cancer, long-term follow-up remains sub-optimal, and the extant 
literature does not clarify how best to care for this growing population in order to minimize 
chronic health conditions and maximize quality of life. Importantly, it has not been established 
that attendance at a specialized survivor clinic provides superior surveillance or long-term health 
outcomes compared to care in the general oncology system or from a knowledgeable family 
doctor. 
 
Regardless of where an AYA cancer survivor receives their follow-up care, it is critical that their 
care focus on the specific risks arising from their prior cancer, and that survivors receive 
appropriate surveillance for late effects along with counselling around healthy lifestyle. To that 
end, the US Institute of Medicine has recognized the need for the development of evidence-based 
clinical practice guidelines for the care of survivors of childhood and adult cancers.[111,112] 
Although numerous guidelines have been created, only a limited number (e.g. National 
Comprehensive Cancer Network [NCCN]) have been created specifically for survivors of AYA 
cancer. However, many of the guidelines written for survivors of childhood cancer include 
younger AYA survivors (e.g. diagnosed before age 21 or 25 years). These are listed in Table 3. 
An important tool for ensuring that survivors are aware of their specific risks and required 
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surveillance is the survivorship care plan (SCP) that contains a cancer history, a summary of 
their therapy, and a plan for surveillance for late effects. In fact, the American College of 
Surgeons Commission on Cancer has made provision of an SCP to at least 50% of eligible 
patients a requirement for designation as a cancer program.[113] Some controversy exists as to 
the effectiveness of an SCP[114] – a systematic review of 13 randomized and 11 non-
randomized studies that assessed the impact of SCPs on health outcomes and health care delivery 
in adult cancer survivors generally showed no impact on physical, functional or psychological 
well-being, although individual studies showed positive effects on receipt of information, 
satisfaction with care and implementation of survivor care recommendations by physicians. 
Despite this, there remains a general consensus that all survivors should receive an SCP.  
Future directions in AYA survivor research 
Survival of AYA cancers continues to improve, and consequently the population of survivors of 
AYA cancers will continue to grow. As survivors age, the long-term consequences of their 
cancer therapies will combine with the normal aging process, and potentially accelerate the 
normal aging process, creating new challenges for survivors and their providers. Studies such as 
the Bone Marrow Transplant Survivor Study (BMTSS) and the St Jude Lifetime Cohort Study 
are examining outcomes such as premature frailty in cohorts that include survivors of AYA 
cancer.  There are many gaps in our knowledge about long-term outcomes in this vulnerable 
population. Some opportunities for future research are suggested in Table 4. Since much of the 
“knowledge” about survivors of AYA cancers has been based on extrapolation of evidence from 
childhood cancer survivor cohorts, there is a need for the creation of survivor cohorts that span 
the full age range of AYA, and do not just focus on adolescents and younger adults. There was a 
recent systematic research prioritisation initiative undertaken in the UK involving AYA 
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survivors, their families, friends, parents, carers and healthcare professionals, which identified 
ten priorities for AYA research.[115] Priorities relevant to survivor care included studying 
psychological supports that can improve psychological well-being, social functioning and mental 
health; interventions to reduce late effects; interventions to support young people returning to 
work; and determining the optimal method and timing  of follow-up in order to minimize 
psychological harm while ensuring early detection of late effects. Beyond research, there is a 
critical need for continued advocacy for AYA with cancer, not just during their therapy but in the 
years after their cure. Quality of survival must receive the same attention as quantity of survival. 
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Table 1: International survivor cohorts that include survivors of AYA cancer 
 
Cohort Name or Registry Geographical location 
Age at 
diagnosis 
(years) 
Study Design Calendar years of diagnosis 
No. of Survivors 
Overall; No. of AYAa 
Survival interval at 
entry 
Teenage and Young Adult 
Cancer Survivor Study 
(TYACSS) 
England & Wales, United 
Kingdom 15-39 
Population-
based 1971-2006 
200,945 AYA 
[14,15,27,40] 5-year survivors 
Yorkshire Specialist Register 
of Cancer in Children and 
Young People (YSRCCYP) 
Yorkshire and Humber 
region, England, United 
Kingdom 
0-29 Population-based 1990-2012 
5,902;  
3,644 AYA 
 
4,580; 2,857 AYA 
No survivorship 
restriction 
 
5-year survivors 
Finnish Cancer Registry Finland 0-34 Population-based 1971-2012 
13,960; 10,770 AYA 
[37]  5-year survivors 
Danish Cancer Registry Denmark 15-39 Population-based 
1943-2009 
 
1943-2004 
43,153 AYA [38] 
 
33,555 AYA [39]  
1-year survivors 
 
5-year survivors 
Scottish Cancer Registry Scotland 0-24 Population-based 1981-2003 
5,229;  
3,053 AYA [11]  5-year survivors 
Swiss Childhood Cancer 
Survivor Study (SCCSS) Switzerland 0-20 
Population-
based 1976-2010 7,600; AYA [116]  5-year survivors 
Adult Life after Childhood 
Cancer in Scandinavia 
(ALiCCS) 
Denmark, Finland, Iceland, 
Norway, Sweden 0-19 
Population-
based 1943-2008 33,160; AYA [116]  1-year survivors 
Dutch Childhood Oncology 
Group LATER (DCOG LATER) The Netherlands 0-17 
Nationwide 
hospital-based 1963-2002 6,165; 401 AYA [117]  5-year survivors 
Initiative to Maximize Progress 
in Adolescent and Young Adult 
Cancer Therapy (IMPACT) 
Ontario, Canada 15-21 Population-based 1992-2012 2,931 AYA 
No survivorship time 
restriction, selected 
diagnosesb 
Childhood, Adolescent, and 
Young Adult Cancer Survivors 
Research Program (CAYACS) 
British Columbia, Canada 20-24 Population-based 1970-2010 4,776 AYA 
No survivorship time 
restriction 
Surveillance, Epidemiology, 
and End Results (SEER) 
Connecticut, Detroit, 
Atlanta, San Francisco-
Oakland, Hawaii, Iowa, New 
15-39 Population-based 1973-2011 148,558 AYA [28]  5-year survivors 
19 
 
Mexico, Seattle-Puget 
Sound, Utah  
Childhood Cancer Survivor 
Study (CCSS) United States 0-20 Hospital-based 1970-1999 
35,937; 
5,600 AYA [116,118]  
5-year survivors, 
selected diagnosesc 
St. Jude Lifetime Cohort Study 
(SJLIFE) 
St. Jude Children’s 
Hospital, Tennessee, 
United States 
0-24 Hospital-based 1962-2009 5,122; 793 AYA 5-year survivors 
 
aDiagnosed between 15-39 years age 
bAcute leukemia (acute lymphoblastic, acute myeloid), Hodgkin lymphoma, non-Hodgkin lymphoma, soft tissue sarcomas, bone sarcomas, and testicular cancer diagnoses 
cLeukemia, CNS tumors, Hodgkin lymphoma, non-Hodgkin lymphoma, Wilms tumor, neuroblastoma, soft tissue sarcoma, and bone tumor diagnoses 
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Table 2: Previous intervention studies aimed at prevention, earlier diagnosis or otherwise 
reducing impact of physical late effects. 
 
A. Previous systematic reviews: 
1. “Health behavior change interventions for teenage and young adult cancer survivors: A systematic review” Pugh 
et al (2016)[103] – contributing primary studies: 
Authors Study Design Participants Target Behavior 
Huang et al, 2014119* RCT N=38, aged 8-18 years Physical activity and diet 
Bélanger et al, 2014120* RCT N=212, aged 18-39 years Physical activity 
Berg et al, 2014121* One-arm 
feasibility 
N=24, aged 18-34 years Physical activity, smoking and alcohol 
Valle et al, 2013122* RCT N=86, aged 21-39 years Physical activity 
Li et al, 2013123* RCT N=71, aged 9-16 years Physical activity 
Hollen et al, 2013124* RCT N=243, aged 14-19 years Smoking and alcohol 
Järvelä et al, 2012125* One-arm 
feasibility 
N=17, aged 16-30 years Physical activity 
Mays et al, 2011126* RCT N=75, aged 11-21 years Diet 
Keats et al, 2008127* Repeated 
measures 
longitudinal 
N=10, aged 14-18 years Physical activity 
Cox et al, 2005128* & 
Hudson et al, 2002129* 
RCT N=266, aged 12-18 years Physical activity, diet, smoking and 
alcohol 
Tyc et al, 2003130* RCT N=103, aged 10-18 years Smoking 
Hollen et al, 1999131* RCT N=64, aged 13-21 years Smoking and alcohol 
2. “Lifestyle behavior interventions delivered using technology in childhood, adolescent and young adult cancer 
survivors: A systematic review” Kopp et al (2017)[104] – contributing primary studies: 
Authors Study Design Participants Target Behavior 
Sabel et al, 2016132* RCT N=13, aged 7-17 years Physical activity 
Berg et al, 2014121* One-arm 
feasibility 
N=24, aged 18-34 years Physical activity, smoking and alcohol 
Huang et al, 2014119* RCT N=38, aged 8-18 years Physical activity and diet 
Valle et al, 2013122* RCT N=86, aged 21-39 years Physical activity 
Rabin et al, 2012133* RCT N=18, aged 18-39 years Physical activity 
Gilliam et al, 2011134* Repeated 
measures 
longitudinal 
N=20, aged 6-18 years Physical activity 
B. Primary research studies not appearing in the systematic reviews above 
Authors Study Design Participants Target Behavior 
Valle et al, 2017135* RCT N=86, aged 21-39 years Physical activity 
Recklitis et al, 2017136* Feasibility N=23, aged 15-39 years Sun protection 
Gill et al, 2016[105] Non-
randomised 2-
group 
comparison 
N=116, aged 18-39 years Physical activity 
Rabin et al, 2016137* RCT N=35, aged 18-39 years Physical activity and meditation 
Valle et al, 2015138* RCT N=86, aged 21-39 years Physical activity 
Emmons et al, 2013[106] RCT N=374, mean age 32 years Smoking cessation 
Schwartz et al, 2016139* RCT N=62, mean age 17 years Physical activity, smoking, sun 
protection and diet 
Brunet140* RCT N=30, aged 15-44 years. 
Ongoing 
Physical activity 
Valle et al141* RCT N=64, aged 18-39 years. 
Ongoing 
Physical activity 
Devine et al142* RCT N=59, aged 13-25 years. Physical activity 
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Ongoing 
Salchow et al143* RCT N=55, median age 23.9 
years. Ongoing. 
Physical activity 
* These references are in Appendix B 
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Table 3: Survivor guidelines applicable to AYA cancer survivors 
 
Publisher Age range at cancer diagnosis Web link 
International Guidelines Harmonization 
Group (IGHG) 
Childhood, adolescence and young 
adulthood  
www.ighg.org 
Children’s Oncology Group (COG) Childhood, adolescence and young 
adulthood 
http://survivorshipguidelines.org/ 
Scottish Intercollegiate Guidelines Network 
(SIGN) 
<24 years  http://www.sign.ac.uk/assets/sign132.pdf 
Children’s Cancer and Leukaemia Group 
(CCLG) 
Childhood https://www.cclg.org.uk/write/MediaUploads/Member
%20area/Treatment%20guidelines/LTFU-full.pdf 
National Comprehensive Cancer Network 
(NCCN) 
15-39 years https://www.nccn.org/professionals/physician_gls/pd
f/aya.pdf 
Dutch Childhood Oncology Group (DCOG-
LATER) 
Pediatric https://www.skion.nl/workspace/uploads/vertaling-
richtlijn-LATER-versie-final-okt-2014_2.pdf 
The Society for Paediatric Oncology and 
Haematology (GPOH; German) 
Childhood, adolescence and young 
adulthood 
https://www.awmf.org/leitlinien/detail/ll/025-003.html 
Swedish Working Group for Long-term 
Follow-up after Childhood Cancer (SALUB) 
Childhood http://www.blf.net/onko/page6/page14/files/Salub_5
_2010_Eng.pdf 
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Table 4: Gaps in research in AYA cancer survivors 
 Creation of cohorts that include the complete range of AYA ages (15-39 years) 
 Creation of cohorts that capture the full spectrum of cancers most common in AYA 
 Characterization and comparison of morbidity and mortality across the AYA age spectrum 
 Factors affecting AYA’ decisions to undergo fertility preservation 
 Factors affecting transition of care after treatment  
 Factors affecting, and health outcomes related to, locus and provider of survivor care 
 The impact of survivor care plans on outcomes 
 Interventions to improve adherence to recommended surveillance for late effects 
 Study of barriers to completing school/obtaining employment after therapy  
 Health promotion intervention studies (e.g. diet, physical activity, smoking cessation) 
 Characterization of the psychosocial support needed by survivors 
 Characterization of the rehabilitation services needed by survivors 
 Characterization of financial toxicity and its risk factors  
 Factors affecting research investment in AYA 
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Appendix A 
 
We performed a systematic search of the literature databases Medline/PubMed (1946–2018), 
Embase (1974–2018) and Ovid MEDLINE In-Process & Other Non-Indexed Citations (to 
November 05, 2018). Search terms for adolescent and young adult cancer survivors and 
interventions were combined in our search in these databases as detailed below.  
The search terms and strategy used were: 
A. Adolescent and young adult cancer: 
 
1.   adolescent and young adult cancer survivor$ (370) 
2.   AYA cancer survivor$ (251) 
3.   survivor$ of adolescent and young adult cancer (50) 
4.  survivor$ of AYA cancer (30) 
5.  teenage and young adult cancer survivor$ 24 
6.  TYA cancer survivor$ (10) 
7.  survivor$ of teenage and young adult cancer (9) 
8.  survivor$ of TYA cancer (0) 
9. young cancer survivor$ (293) 
 
10.    1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7OR 8 OR 9 or 10 (838) 
 
B. Intervention, prevention, screening, early diagnosis, RCT, randomised control trial 
and clinical trial: 
 
11.    prevent$ (4666295) 
12.     early diagnosis (239994) 
13.     screen$ (1880417) 
14.     intervention (1299072) 
15.     rct (49184) 
16.     randomi$ controlled trial (1184603) 
17.     clinical trial (2104859) 
 
18     11 OR 12 OR 13 OR 14 OR 15 OR 16 or 17 (9267603) 
 
C. Combined search adolescent and young adult cancer and subsequent cancers: 
 
19.    10 AND 18 (245) 
 
The searches were performed as above on 06/11/18. The result was 245 references.  
We also conducted a search within the Cochrane review library using the terms “adolescent and 
young adult cancer survivor$” and “teenage and young adult cancer survivor$”. The result was 3 
Cochrane reviews and 114 trials.  
From these resulting references, title and abstract were read for any interventions in AYA cancer 
survivors relating to physical effects, principally second cancers, cardiac, respiratory and fertility 
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outcomes. Irrelevant references were excluded for the following reasons: they were reporting 
solely the occurrence of late effects; the intervention was for psychological outcomes; they were 
not an intervention; they related exclusively to health care use and/or type of follow-up care. 
After excluding these studies, further exclusions were made if the participants were not AYA i.e. 
not in the age range of 15-39 years. Finally, duplicates were removed. Please see the flow chart 
below for further details on this process. 
 
From Medline  and Embase 
databases search 
 From Cochrane library search 
 
      
      
245 references 
 
  3 Cochrane reviews  114 Trials 
 
      
      
      
 217 references excluded based on screening of title 
and/or abstract. Duplicates and trials, if they had 
published results and were included in the Medline 
search, were removed. 
 
      
      
      
 20 full text articles, 6 trials and 2 Cochrane reviews 
were assessed for eligibility 
 
      
      
      
 Studies included: 
- 2 systematic reviews, which included 16 full text 
articles, 
- 7 primary research full text articles, 
- 4 ongoing trials; 3 with no results published, 1 with 
interim published results. 
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Appendix B 
References from the review of the literature to identify interventions aimed at preventing, 
diagnosing or mitigating the impact of late effects in survivors of AYA cancer. 
 
References: 
119. Huang JS, Dillon L, Terrones L, et al. Fit4Life: a weight loss intervention for children 
who have survived childhood leukemia. Pediatr Blood  Cancer 2014:61(5):894-900. 
120. Bélanger LJ, Mummery WK, Clark AM, et al. Effects of targeted print materials on 
physical activity and quality of life in young adult cancer survivors during and after treatment: an 
exploratory randomized controlled trial. J AdolescYoung Adult Oncol 2014:3(2):83-91. 
121. Berg CJ, Stratton E, Giblin J, et al. Pilot results of an online intervention targeting health 
promoting behaviors among young adult cancer survivors. Psychooncology 2014:23(10):1196-
1199. 
122. Valle CG, Tate DF, Mayer DK,et al. A randomized trial of a Facebook-based physical 
activity intervention for young adult cancer survivors. J Cancer Surviv 2013:7(3):355-368. 
123. Li HW, Chung OKJ, Ho KY,et al. Effectiveness of an integrated adventure ‐based 
training and health education program in promoting regular physical activity among childhood 
cancer survivors. Psychooncology 2013:22(11):2601-2610. 
124. Hollen PJ, Tyc VL, Donnangelo MSF, et al. A substance use decision aid for medically-
at-risk adolescents: results of a randomized controlled trial for cancer-surviving adolescents. 
Cancer Nursing 2013:36(5):355-367. 
125. Järvelä LS, Kemppainen J, Niinikoski H, et al. Effects of a home-based exercise program 
on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic 
leukemia. Pediatr Blood Cancer 2012:59(1):155-160. 
126. Mays D, Black JD, Mosher RB,et al. Efficacy of the Survivor Health and Resilience 
Education (SHARE) program to improve bone health behaviors among adolescent survivors of 
childhood cancer. Ann Behav Med 2011:42(1):91-98. 
127. Keats MR, Culos-Reed SN. A community-based physical activity program for 
adolescents with cancer (Project TREK): program feasibility and preliminary findings. J Pediatr 
Hematol Oncol 2008:30(4):272-280. 
128. Cox CL, McLaughlin RA, Rai SN,et al. Adolescent survivors: A secondary analysis of a 
clinical trial targeting behaviour change. Pediatr Blood  Cancer 2005:45(2):144-154. 
129. Hudson MM, Tyc VL, Srivastava DK, et al. Multi-component behavioural intervention to 
promote health protective behaviours in childhood cancer survivors: The Protect Study. Med 
Pediatr Oncol 2002:39(1):2-11. 
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130. Tyc VL, Rai SN, Lensing S, et al. Intervention to reduce intentions to use tobacco among 
pediatric cancer survivors. J Clin Oncol 2003:21(7):1366-1372. 
131. Hollen PJ, Hobbie WL, Finley SM. Testing the effects of a decision-making and risk-
reduction program for cancer-surviving adolescents. Oncol Nurs Forum 1999:26(9):1475-1486. 
132. Sabel M, Sjölund A, Broeren J, et al. Active video gaming improves body coordination in 
survivors of childhood brain tumours. Disabil Rehabil 2016:38(21):2073-2084. 
133. Rabin C, Dunsiger S, Ness KK,et al. Internet-based physical activity intervention 
targeting young adult cancer survivors. J Adolesc Young Adult Oncol 2012:1(4):188-194. 
134. Gilliam MB, Ross K, Futch L, et al. A pilot study evaluation of a web-based token 
economy to increase adherence with a community-based exercise intervention in child and 
adolescent cancer survivors. Rehabil Oncol 2011:29(2):16-22. 
135. Valle CG, Tate DF. Engagement of young adult cancer survivors within a Facebook-
based physical activity intervention. Transl Behav Med 2017;7(4):667-679. 
136. Recklitis CJ, Bakan J, Werchniak AE, et al. Using appearance-based messages to 
increase sun protection in adolescent young adult cancer survivors: A pilot study of ultraviolet 
light photography. J Adolesc Young Adult Oncol 2017:6(3):477-481. 
137. Rabin C, Pinto B, Fava J. Randomized trial of a physical activity and meditation 
intervention for young adult cancer survivors. J Adolesc Young Adult Oncol 2016:5(1):41-47. 
138. Valle CG, Tate DF, Mayer DK,et al. Exploring mediators of physical activity in young 
adult cancer survivors: evidence from a randomized trial of a Facebook-based physical activity 
intervention. J Adolesc Young Adult Oncol 2015:4(1):26-33. 
139. Schwartz LA, Daniel LC, Butler E, et al. A pilot text messaging intervention for 
adolescents and young adults recently off treatment for cancer. J Adolesc Health 2016;58(2):S30. 
140. Brunet J. Physical activity for adolescent and young adult cancer survivors. 
https://clinicaltrials.gov/ct2/show/NCT03016728. 2018. 
141. Valle CG, Salsman JM. mHealth. Physical activity intervention for survivors of 
adolescent and young adult cancers (THRIVE). 
https://clinicaltrials.gov/ct2/show/NCT03386383. 2018. 
142. Devine K. Mobile health fitness program for adolescent and young adult childhood 
cancer survivors (TLC FIT) https://clinicaltrials.gov/ct2/show/NCT02688192. 2018. 
143. Salchow J, Jensen W, Koch B, et al. Effects of a structured intervention program to 
improve physical activity of adolescents and young adult cancer survivors (AYA) – Interim 
analysis of a randomized controlled trial – Motivate AYA – MAYA trial. Oncol Res Treat 
2017;40(suppl 3):215;V730. DOI: 10.1159/000479566  
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